NUVALENT, INC.: 10-Q filed 2021-09-08
What NUVALENT, INC. reported in its quarterly report filed 2021-09-08 (fiscal Q2 2021): 27 published measures, 84 facts as tagged in accession 0001193125-21-267350.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2021-09-08
- Fiscal period
- fiscal Q2 2021
- Accession
- 0001193125-21-267350 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All NUVALENT, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | 143,502,000 | USD | |
| At 2020-12-31 | 10,646,000 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | 5,829,000 | USD | |
| At 2020-12-31 | 6,615,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | -47,740,000 | USD | |
| At 2021-03-31 | -38,625,000 | USD | |
| At 2020-12-31 | -31,323,000 | USD | |
| At 2020-06-30 | -20,053,000 | USD | |
| At 2020-03-31 | -11,274,000 | USD | |
| At 2019-12-31 | -17,256,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | 138,919,000 | USD | |
| At 2020-12-31 | 10,332,000 | USD | |
| At 2020-06-30 | 9,325,000 | USD | |
| At 2019-12-31 | 3,016,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-04-01 to 2021-06-30 | -9,838,000 | USD | 91 |
| 2021-01-01 to 2021-06-30 | -16,623,000 | USD | 181 |
| 2021-01-01 to 2021-03-31 | -6,785,000 | USD | 90 |
| 2020-01-01 to 2020-12-31 | -14,600,000 | USD | 366 |
| 2020-04-01 to 2020-06-30 | -8,557,000 | USD | 91 |
| 2020-01-01 to 2020-06-30 | -3,198,000 | USD | 182 |
| 2020-01-01 to 2020-03-31 | 5,359,000 | USD | 91 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-06-30 | -15,645,000 | USD | 181 |
| 2020-01-01 to 2020-06-30 | -5,941,000 | USD | 182 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-06-30 | 144,232,000 | USD | 181 |
| 2020-01-01 to 2020-06-30 | 12,250,000 | USD | 182 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | -48,508,000 | USD | |
| At 2020-12-31 | -31,885,000 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-04-01 to 2021-06-30 | 3,106,152 | shares | 91 |
| 2021-01-01 to 2021-06-30 | 3,095,639 | shares | 181 |
| 2020-04-01 to 2020-06-30 | 3,037,974 | shares | 91 |
| 2020-01-01 to 2020-06-30 | 2,675,827 | shares | 182 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-04-01 to 2021-06-30 | 3,106,152 | shares | 91 |
| 2021-01-01 to 2021-06-30 | 3,095,639 | shares | 181 |
| 2020-04-01 to 2020-06-30 | 3,037,974 | shares | 91 |
| 2020-01-01 to 2020-06-30 | 2,675,827 | shares | 182 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-04-01 to 2021-06-30 | -3.17 | USD/shares | 91 |
| 2021-01-01 to 2021-06-30 | -5.37 | USD/shares | 181 |
| 2020-04-01 to 2020-06-30 | -2.82 | USD/shares | 91 |
| 2020-01-01 to 2020-06-30 | -1.2 | USD/shares | 182 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-04-01 to 2021-06-30 | -3.17 | USD/shares | 91 |
| 2021-01-01 to 2021-06-30 | -5.37 | USD/shares | 181 |
| 2020-04-01 to 2020-06-30 | -2.82 | USD/shares | 91 |
| 2020-01-01 to 2020-06-30 | -1.2 | USD/shares | 182 |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-06-30 | 790,000 | USD | 181 |
| 2020-01-01 to 2020-06-30 | 652,000 | USD | 182 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-04-01 to 2021-06-30 | -9,850,000 | USD | 91 |
| 2021-01-01 to 2021-06-30 | -16,012,000 | USD | 181 |
| 2020-04-01 to 2020-06-30 | -4,006,000 | USD | 91 |
| 2020-01-01 to 2020-06-30 | -7,651,000 | USD | 182 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | 139,281,000 | USD | |
| At 2020-12-31 | 10,646,000 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | 5,829,000 | USD | |
| At 2020-12-31 | 4,380,000 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | 3,798,000 | USD | |
| At 2020-12-31 | 1,252,000 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-04-01 to 2021-06-30 | 9,850,000 | USD | 91 |
| 2021-01-01 to 2021-06-30 | 16,012,000 | USD | 181 |
| 2020-04-01 to 2020-06-30 | 4,006,000 | USD | 91 |
| 2020-01-01 to 2020-06-30 | 7,651,000 | USD | 182 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-04-01 to 2021-06-30 | 7,826,000 | USD | 91 |
| 2021-01-01 to 2021-06-30 | 13,310,000 | USD | 181 |
| 2020-04-01 to 2020-06-30 | 3,657,000 | USD | 91 |
| 2020-01-01 to 2020-06-30 | 6,983,000 | USD | 182 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | 3,129,384 | shares | |
| At 2020-12-31 | 3,129,384 | shares |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | 2,503,000 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | 2,031,000 | USD | |
| At 2020-12-31 | 1,171,000 | USD |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-06-30 | -16,623,000 | USD | 181 |
| 2020-01-01 to 2020-06-30 | -3,198,000 | USD | 182 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-04-01 to 2021-06-30 | 2,024,000 | USD | 91 |
| 2021-01-01 to 2021-06-30 | 2,702,000 | USD | 181 |
| 2020-04-01 to 2020-06-30 | 349,000 | USD | 91 |
| 2020-01-01 to 2020-06-30 | 668,000 | USD | 182 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-04-01 to 2021-06-30 | 12,000 | USD | 91 |
| 2021-01-01 to 2021-06-30 | 24,000 | USD | 181 |
| 2020-04-01 to 2020-06-30 | -9,000 | USD | 91 |
| 2020-01-01 to 2020-06-30 | -18,000 | USD | 182 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-04-01 to 2021-06-30 | 12,000 | USD | 91 |
| 2021-01-01 to 2021-06-30 | -611,000 | USD | 181 |
| 2020-04-01 to 2020-06-30 | -4,551,000 | USD | 91 |
| 2020-01-01 to 2020-06-30 | 4,453,000 | USD | 182 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-06-30 | 1,823,000 | USD | 181 |
| 2020-01-01 to 2020-06-30 | 641,000 | USD | 182 |
Inspect the source
- Entity
- NUVALENT, INC. / CIK 0001861560
- Captured
- 2026-09-21T17:31:51.072Z
- SEC response SHA-256
3f201cdcd18a2386f08e99ffc863b70592f2c20159fd9c22ee61968a4aa8f8c4
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001861560.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))